Beyond inducing weight loss, these treatments have demonstrated benefits on obesity-related complications, including neuropsychiatric and substance use disorders, peripheral vascular disease, arthritis, MASLD, hypertension and renal disorders, positioning them as a central focus in current obesity research [3]
This was regarded as a well-functioning cytoprotection loop (brainperiphery) that might consistently occur as an implementation of the full complexities of the braingut axis function in BPC 157 therapy [1,3,4]
These studies suggest that the peptide is well-tolerated, with no known toxic limitbut we dont yet know if the same results would occur in humans
Sikiric P, Sever M, Krezic I, Vranes H, Kalogjera L, Smoday IM, Vukovic V, Oroz K, Coric L, Skoro M, Kavelj I, Zubcic S, Sikiric S, Beketic Oreskovic L, Oreskovic I, Blagaic V, Brcic K, Strbe S, Staresinic M, Boban Blagaic A, Skrtic A, Seiwerth S